Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4615-1173-1_3DOI Listing

Publication Analysis

Top Keywords

mdr mrp
4
mrp gene
4
gene families
4
families cellular
4
cellular determinant
4
determinant factors
4
factors resistance
4
resistance clinical
4
clinical anticancer
4
anticancer agents
4

Similar Publications

The transmission of antibiotic resistance (AR) from farm animals to healthy human communities, beyond the food chain, is often facilitated by biological vectors, notably houseflies (Musca domestica). This study aimed to evaluate the role of M. domestica collected from commercial broiler chicken farms as a carrier of multidrug-resistant (MDR), extended-spectrum β-lactamase (ESBL)-producing Escherichia coli.

View Article and Find Full Text PDF

Breast cancer is one of the most common cancers among women. Nowadays postoperative adjuvant chemotherapy is the mainstay for clinical treatment of breast cancer. However, the emergence of multidrug resistance (MDR) in breast cancer has become a main reason for the failure of clinical chemotherapy.

View Article and Find Full Text PDF

Hypertensive Nephropathy Changes the Expression of Drug-Metabolizing Enzymes and Transporters in Spontaneously Hypertensive Rat Liver and Kidney.

Eur J Drug Metab Pharmacokinet

November 2024

Changsha Research and Development Center on Obstetric and Gynecologic Traditional Chinese Medicine Preparation, NHC Key Laboratory of Birth Defects Research, Prevention and Treatment, Hunan Provincial Maternal and Child Health Care Hospital, No. 53 Xiangchun Road, Kaifu District, Changsha, 410008, Hunan, China.

Background And Objectives: Hypertensive nephropathy (HN) has become one of the main causes of end-stage renal disease. Drug combination therapy is a common clinical treatment for HN. However, the impact of HN on drug-metabolizing enzymes and transporters, which may lead to drug-drug interactions (DDIs) and even trigger toxic side effects, remains unclear.

View Article and Find Full Text PDF

Evaluation of Novel Diaza Cage Compounds as MRP Modulators in Cancer Cells.

Anticancer Agents Med Chem

August 2024

Institute of Pharmacy, Martin-Luther, University Halle, Wittenberg, Wolfgang, Langenbeck-Str. 4, 06120 Halle, Germany.

Aim: Novel MRP modulators are needed to combat MRP-mediated multidrug resistance (MDR) in cancer cells.

Background: Anticancer drug resistance is the main problem in cancer therapy. Causative multidrug efflux pumps are attractive target structures for the development of inhibitors of their activity.

View Article and Find Full Text PDF

Hepatocellular carcinoma is the most common type of primary liver cancer. However, multidrug resistance (MDR) is a major obstacle to the effective chemotherapy of cancer cells. This report documents the rational design, synthesis, and biological evaluation of a novel series of triazolotriazines substituted with CHNH-linked pyridine for use as dual c-Met/MDR inhibitors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!